Development Of An Integrated Recovery Process For Recombinant Hepatitis B Core Antigen

Hepatitis B core antigen (HBcAg) expressed intracellularly in Escherichia coli (E. coli) has great potential and high demand in pharmaceutical market. The main objective of this study was to develop an efficient and cost effective protocol for the recovery of recombinant HBcAg. Cell disruption is th...

Full description

Saved in:

Bibliographic Details
Main Author:	Ho, Chin Woi
Format:	Thesis
Language:	English English
Published:	2007
Subjects:	Hepatitis associated antigen Escherichia coli - Malaysia
Online Access:	http://psasir.upm.edu.my/id/eprint/5210/1/FK_2007_27.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-upm-ir.5210
record_format	uketd_dc
spelling	my-upm-ir.52102013-05-27T07:21:10Z Development Of An Integrated Recovery Process For Recombinant Hepatitis B Core Antigen 2007 Ho, Chin Woi Hepatitis B core antigen (HBcAg) expressed intracellularly in Escherichia coli (E. coli) has great potential and high demand in pharmaceutical market. The main objective of this study was to develop an efficient and cost effective protocol for the recovery of recombinant HBcAg. Cell disruption is the prerequisite step to release the intracellular HBcAg to the surrounding medium prior to subsequent purification processes. In the current study, E. coli was disrupted by mechanical method of bead milling. Bead milling can be operated either in batch or continuous recycling mode. The performance of bead milling is affected by parameters such as impeller tip speed, biomass concentration, bead loading and feed flow rate. Thus, in the first chapter of the study, the effects of these parameters on different modes of operation were investigated. The effect of these operation modes on the subsequent downstream processing was also examined. In the second chapter of the study, a purification protocol for the recovery of HBcAg was developed. The HBcAg was initially purified by the integrated operation of batch mode bead milling and expanded bed adsorption (EBA), and subsequently purified by size exclusion chromatography (SEC). The results of the cell disruption study show that the optimum disruption of E. coli and release of intracellular HBcAg in batch mode bead milling was achieved at impeller tip speed of 14 m/s, biomass concentration of 20% (w/v) and bead loading of 80% (v/v), whilst the performance of continuous recycling bead milling was peak at impeller tip speed of 14 m/s, biomass concentration of 10% (w/v) and feed flow rate of 15 L/h. Batch mode was ideal for the batch anion-exchange adsorption, in which a HBcAg yield of 34.3%, a HBcAg purity of 65% and a purification factor of 2.86 was achieved. In the purification study, the product yield, product purity and purification factor achieved in the integrated EBA process was 55%, 42.3% and 1.96, respectively. The partially purified HBcAg was then further purified by SEC, in which a product yield of 42.4% was obtained. The SEC purification has also yielded a HBcAg purity of 88.2%, which corresponded to a purification factor of 4.08. The purified HBcAg was confirmed to be functionally active and hence, can be used in the development of hepatitis B virus (HBV) diagnostic kits. Hepatitis associated antigen Escherichia coli - Malaysia 2007 Thesis http://psasir.upm.edu.my/id/eprint/5210/ http://psasir.upm.edu.my/id/eprint/5210/1/FK_2007_27.pdf application/pdf en public masters Universiti Putra Malaysia Hepatitis associated antigen Escherichia coli - Malaysia Faculty of Engineering English
institution	Universiti Putra Malaysia
collection	PSAS Institutional Repository
language	English English
topic	Hepatitis associated antigen Escherichia coli - Malaysia
spellingShingle	Hepatitis associated antigen Escherichia coli - Malaysia Ho, Chin Woi Development Of An Integrated Recovery Process For Recombinant Hepatitis B Core Antigen
description	Hepatitis B core antigen (HBcAg) expressed intracellularly in Escherichia coli (E. coli) has great potential and high demand in pharmaceutical market. The main objective of this study was to develop an efficient and cost effective protocol for the recovery of recombinant HBcAg. Cell disruption is the prerequisite step to release the intracellular HBcAg to the surrounding medium prior to subsequent purification processes. In the current study, E. coli was disrupted by mechanical method of bead milling. Bead milling can be operated either in batch or continuous recycling mode. The performance of bead milling is affected by parameters such as impeller tip speed, biomass concentration, bead loading and feed flow rate. Thus, in the first chapter of the study, the effects of these parameters on different modes of operation were investigated. The effect of these operation modes on the subsequent downstream processing was also examined. In the second chapter of the study, a purification protocol for the recovery of HBcAg was developed. The HBcAg was initially purified by the integrated operation of batch mode bead milling and expanded bed adsorption (EBA), and subsequently purified by size exclusion chromatography (SEC). The results of the cell disruption study show that the optimum disruption of E. coli and release of intracellular HBcAg in batch mode bead milling was achieved at impeller tip speed of 14 m/s, biomass concentration of 20% (w/v) and bead loading of 80% (v/v), whilst the performance of continuous recycling bead milling was peak at impeller tip speed of 14 m/s, biomass concentration of 10% (w/v) and feed flow rate of 15 L/h. Batch mode was ideal for the batch anion-exchange adsorption, in which a HBcAg yield of 34.3%, a HBcAg purity of 65% and a purification factor of 2.86 was achieved. In the purification study, the product yield, product purity and purification factor achieved in the integrated EBA process was 55%, 42.3% and 1.96, respectively. The partially purified HBcAg was then further purified by SEC, in which a product yield of 42.4% was obtained. The SEC purification has also yielded a HBcAg purity of 88.2%, which corresponded to a purification factor of 4.08. The purified HBcAg was confirmed to be functionally active and hence, can be used in the development of hepatitis B virus (HBV) diagnostic kits.
format	Thesis
qualification_level	Master's degree
author	Ho, Chin Woi
author_facet	Ho, Chin Woi
author_sort	Ho, Chin Woi
title	Development Of An Integrated Recovery Process For Recombinant Hepatitis B Core Antigen
title_short	Development Of An Integrated Recovery Process For Recombinant Hepatitis B Core Antigen
title_full	Development Of An Integrated Recovery Process For Recombinant Hepatitis B Core Antigen
title_fullStr	Development Of An Integrated Recovery Process For Recombinant Hepatitis B Core Antigen
title_full_unstemmed	Development Of An Integrated Recovery Process For Recombinant Hepatitis B Core Antigen
title_sort	development of an integrated recovery process for recombinant hepatitis b core antigen
granting_institution	Universiti Putra Malaysia
granting_department	Faculty of Engineering
publishDate	2007
url	http://psasir.upm.edu.my/id/eprint/5210/1/FK_2007_27.pdf
_version_	1747810374127714304

Development Of An Integrated Recovery Process For Recombinant Hepatitis B Core Antigen

Similar Items